Johnson & Johnson said Friday that it is seeing a jump in demand for Tylenol and other self-care products, as the global COVID-19 pandemic prompts people to stock up on essentials, as reported in the Financial Post.
The company indicated that it was shipping its stock in a "controlled manner" and that its manufacturing sites had ramped up production to ensure supply.
Nevertheless, Johnson & Johnson does not anticipate a shortage of Tylenol even though the drug "may have temporarily run out of stock at one location."
Fears of potential drug shortages were amplified last week after India, the world's main supplier of generic drugs, restricted the export of some ingredients as well as medicines including paracetamol, known as Tylenol in the US.
To read more NewsPoints articles, click here.